133 related articles for article (PubMed ID: 12710772)
21. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
[TBL] [Abstract][Full Text] [Related]
22. [Pseudohypoparathyroidism type I and vitamin D therapy].
Kovarik J; Weissel M; Neuwirth G; Krepler P; Willvonseder R
Acta Med Austriaca; 1978; 5(3):106-9. PubMed ID: 222102
[TBL] [Abstract][Full Text] [Related]
23. Psedohypoparathyroidism in newborn - a rare presentation.
Sajitha S; Krishnamoorthy PN; Shenoy UV
Indian Pediatr; 2003 Jan; 40(1):47-9. PubMed ID: 12554918
[TBL] [Abstract][Full Text] [Related]
24. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY
J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
26. Ratio of baseline level/maximum level of serum PTH in pseudohypoparathyroidism and primary hyperparathyroidism.
Mizunashi K; Furukawa Y; Goto MM
Calcif Tissue Int; 1998 Feb; 62(2):99-103. PubMed ID: 9437041
[TBL] [Abstract][Full Text] [Related]
27. The development of pseudohypoparathyroidism. Involvement of progressively increasing serum parathyroid hormone concentrations, increased 1,25-dihydroxyvitamin D concentrations, and 'migratory' subcutaneous calcifications.
Tsang RC; Venkataraman P; Ho M; Steichen JJ; Whitsett J; Greer F
Am J Dis Child; 1984 Jul; 138(7):654-8. PubMed ID: 6328970
[TBL] [Abstract][Full Text] [Related]
28. Distribution of circulating immunoreactive components of parathyroid hormone in normal subjects and in patients with primary and secondary hyperparathyroidism: the role of the kidney and of the serum calcium concentration.
Dambacher MA; Fischer JA; Hunziker WH; Born W; Moran J; Roth HR; Delvin EE; Glorieux FH
Clin Sci (Lond); 1979 Nov; 57(5):435-43. PubMed ID: 519952
[TBL] [Abstract][Full Text] [Related]
29. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism.
Breslau NA; Notman DD; Canterbury JM; Moses AM
Am J Med; 1980 Jun; 68(6):856-60. PubMed ID: 6247909
[TBL] [Abstract][Full Text] [Related]
30. [Pseudohypoparathyroidism, calcifying arteriopathy and ischemic skin necrosis].
Michel B; Wimpfheimer C; Rizzoli R
Schweiz Med Wochenschr; 1985 Mar; 115(12):418-21. PubMed ID: 2986283
[TBL] [Abstract][Full Text] [Related]
31. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE
J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395
[TBL] [Abstract][Full Text] [Related]
32. [Transitory pseudohypoparathyroidism in the newborn infant].
Schaumberger E; Hohenauer L; Sommer R
Klin Padiatr; 1986; 198(4):349-52. PubMed ID: 3762009
[TBL] [Abstract][Full Text] [Related]
33. Control of parathyroid function in patients with a short history of hemodialysis.
Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
[TBL] [Abstract][Full Text] [Related]
34. Effective long-term treatment of pseudohypoparathyroidism with oral 1alpha-hydroxy- and 1,25-dihydroxy-cholecalciferol.
Werder EA; Kind HP; Egert F; Fischer JA; Prader A
J Pediatr; 1976 Aug; 89(2):266-8. PubMed ID: 940021
[No Abstract] [Full Text] [Related]
35. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
Kruse K; Kracht U; Wohlfart K; Kruse U
Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
[TBL] [Abstract][Full Text] [Related]
36. An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism: comparison with vitamin D deficiency.
Allgrove J; Chayen J; Jayaweera P; O'Riordan JL
Clin Endocrinol (Oxf); 1984 May; 20(5):503-14. PubMed ID: 6744632
[TBL] [Abstract][Full Text] [Related]
37. Improvement in abnormal secretion of thyrotropin and gonadotropin after restoration of serum calcium is pseudohypoparathyroidism.
Suzuki H; Kasai K; Shimoda S; Mori K; Miyasaka M
Endocrinol Jpn; 1982 Feb; 29(1):69-75. PubMed ID: 6286295
[TBL] [Abstract][Full Text] [Related]
38. [Pseudohypoparathyroidism or vitamin D deficiency? Report of one case].
López JM; Carrasco CM
Rev Med Chil; 2004 Dec; 132(12):1527-31. PubMed ID: 15743166
[TBL] [Abstract][Full Text] [Related]
39. A case of pseudohypoparathyroidism.
Epstein S; Sagel J; Jackson WP
S Afr Med J; 1971 Jan; 45(5):115-7. PubMed ID: 5546496
[No Abstract] [Full Text] [Related]
40. [Primary hypothyroidism revealing pseudohypoparathyroidism without hypocalcemia and hyperphosphoremia].
Coutant R; Carel JC; Mathivon L; Boisson Lesage C; Renier D; Garabédian M; Chaussain JL
Arch Pediatr; 1997 May; 4(5):433-7. PubMed ID: 9230993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
